APRICUS BIOSCIENCES INC - COM NEW (APRI)

CUSIP: 03832V307

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM NEW
Total 13F shares
5,628,806
Share change
+3,154,443
Total reported value
$1,746,253
Price per share
$0.31
Number of holders
18
Value change
+$854,064
Number of buys
7
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 03832V307?
CUSIP 03832V307 identifies APRI - APRICUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APRICUS BIOSCIENCES INC - COM NEW (APRI) as of Q3 2018

As of 30 Sep 2018, APRICUS BIOSCIENCES INC - COM NEW (APRI) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,628,806 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, GEODE CAPITAL MANAGEMENT, LLC, Vanguard Group Inc, ARDSLEY ADVISORY PARTNERS, Healthcare Value Capital, LLC, BlackRock Inc., Virtu Financial LLC, MML INVESTORS SERVICES, LLC, CITADEL ADVISORS LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.